2021-11-16-世界卫生组织-Cervical_cancer_Djibouti_2021_country_profile_1页_64kb

Overview

This report summarizes cervical cancer data for Djibouti, based on the 2021 WHO cervical cancer country profile. It covers morbidity and mortality, prevention strategies (primary and secondary), treatment availability, and progress toward WHO elimination targets for 2030.

Morbidity and Mortality

• Age-standardized cervical cancer incidence rate in 2020: 15.3 per 100,000 women.
• Cumulative risk of cervical cancer by age 74: 1.8%.
• Cervical cancer deaths in 2019: 3,200.
• Mortality-to-incidence ratio in 2020: 0.7.
• Population-based cancer registry exists (as of 2021).
• Total female population in 2019: 462,000.
• Total female deaths in 2019: 3,200.

Primary Prevention

• HPV vaccination: Not included in the national immunization schedule.
  • Programme coverage among girls ages 9-14: 0% for first dose, 20% for final dose.
  • Coverage by age 15: No data.
• Other factors:
  • Tobacco use prevalence (women aged 15+): 0.13%.
  • Condom use at last high-risk sex: Less than 7%.
  • HIV incidence (women aged 15+): No data.

Secondary Prevention

• No national cervical cancer screening program.
• Ever screened for cervical cancer (among women aged 30-49): 7%.
• No guidelines or referral system to strengthen early detection at primary health care levels.

Treatment and Supportive Care

• National guidelines on cervical cancer management exist (2021).
• Limited resources: No radiotherapy or brachytherapy units, few medical staff available, no cancer centers or specialized doctors like radiation oncologists.
• Palliative care for non-communicable diseases is generally not available in the public health system.

WHO Elimination Strategy Targets

• Not met; HPV vaccination coverage and screening rates are low, and resources for treatment are inadequate.
• Key indicators such as full vaccination by age 15 are absent, and data is often not available (ND).